The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116261966 11626196 6 F 20150825 20160725 20151013 20160802 EXP GB-BAUSCH-BL-2015-022639 BAUSCH AND LOMB 77.00 YR M Y 172.00000 KG 20160802 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116261966 11626196 1 PS PREDNISOLONE. PREDNISOLONE 1 Oral U 40070 100 MG QD
116261966 11626196 2 SS PREDNISOLONE. PREDNISOLONE 1 U 40070
116261966 11626196 3 SS OMEPRAZOLE. OMEPRAZOLE 1 Oral U 0 40 MG QD
116261966 11626196 4 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) U 0 1400 MG QD
116261966 11626196 5 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 U 0
116261966 11626196 6 SS FUROSEMIDE. FUROSEMIDE 1 Oral Y 0 40 MG QD
116261966 11626196 7 SS FUROSEMIDE. FUROSEMIDE 1 Oral Y 0 20 MG QD
116261966 11626196 8 SS INOTUZUMAB OZOGAMICIN INOTUZUMAB OZOGAMICIN 1 Intravenous (not otherwise specified) 0 1.5 MG QD
116261966 11626196 9 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) U 0 720 MG QD
116261966 11626196 10 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) U 0 375 MG/M**2 QD
116261966 11626196 11 SS VINCRISTINE VINCRISTINE 1 Intravenous (not otherwise specified) U 0 2 MG QD
116261966 11626196 12 C ALLOPURINOL. ALLOPURINOL 1 Oral 0 300 MG QD
116261966 11626196 13 C ALLOPURINOL. ALLOPURINOL 1 0
116261966 11626196 14 C ASPIRIN. ASPIRIN 1 Oral 0 75 MG QD
116261966 11626196 15 C CHLORPHENAMINE CHLORPHENIRAMINE MALEATE 1 Intravenous (not otherwise specified) 0 10 MG QD
116261966 11626196 16 C DIGOXIN. DIGOXIN 1 Unknown 0
116261966 11626196 17 C DIGOXIN. DIGOXIN 1 Oral 0 125 UG QD
116261966 11626196 18 C FILGRASTIM FILGRASTIM 1 Subcutaneous 0 300 UG QD
116261966 11626196 19 C FLUCONAZOLE. FLUCONAZOLE 1 Oral 0 50 MG QD
116261966 11626196 20 C HYDROXYCHLOROQUINE HYDROXYCHLOROQUINE 1 Oral 0 200 MG BID
116261966 11626196 21 C LEFLUNOMIDE. LEFLUNOMIDE 1 Oral 0 20 MG QD
116261966 11626196 22 C METOCLOPRAMIDE. METOCLOPRAMIDE 1 Oral AS NECESSARY 0
116261966 11626196 23 C ONDANSETRON ONDANSETRON 1 Oral 0 8 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116261966 11626196 1 Diffuse large B-cell lymphoma
116261966 11626196 2 Neoplasm malignant
116261966 11626196 3 Gastrointestinal haemorrhage
116261966 11626196 4 Diffuse large B-cell lymphoma
116261966 11626196 5 Neoplasm malignant
116261966 11626196 6 Cardiac disorder
116261966 11626196 8 Diffuse large B-cell lymphoma
116261966 11626196 9 Diffuse large B-cell lymphoma
116261966 11626196 10 Neoplasm malignant
116261966 11626196 11 Diffuse large B-cell lymphoma
116261966 11626196 12 Prophylaxis
116261966 11626196 13 Gout
116261966 11626196 14 Aortic valve replacement
116261966 11626196 15 Unevaluable event
116261966 11626196 16 Atrial fibrillation
116261966 11626196 18 White blood cell count
116261966 11626196 19 Antifungal prophylaxis
116261966 11626196 20 Rheumatoid arthritis
116261966 11626196 21 Rheumatoid arthritis
116261966 11626196 22 Vomiting
116261966 11626196 23 Vomiting

Outcome of event

Event ID CASEID OUTC COD
116261966 11626196 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
116261966 11626196 Blood lactic acid increased
116261966 11626196 Hyponatraemia
116261966 11626196 Lower respiratory tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116261966 11626196 1 20150820 20150824 0
116261966 11626196 3 20150826 0
116261966 11626196 4 20150820 20150820 0
116261966 11626196 6 20150826 0
116261966 11626196 8 20150821 20150821 0
116261966 11626196 9 20150820 20150820 0
116261966 11626196 11 20150820 20150820 0
116261966 11626196 12 20150815 20150826 0
116261966 11626196 14 20150826 0
116261966 11626196 15 20150820 20150820 0
116261966 11626196 16 20150815 20150826 0
116261966 11626196 17 20150826 0
116261966 11626196 18 20150823 20150826 0
116261966 11626196 19 20150815 20150826 0
116261966 11626196 20 20150814 20150826 0
116261966 11626196 21 201107 20150826 0
116261966 11626196 22 20150820 20150826 0
116261966 11626196 23 20150820 20150820 0